Your browser doesn't support javascript.
loading
Author Correction: Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions.
Thézénas, Marie-Laëtitia; De Leo, Bianca; Laux-Biehlmann, Alexis; Bafligil, Cemsel; Elger, Bernd; Tapmeier, Thomas; Morten, Karl; Rahmioglu, Nilufer; Dakin, Stephanie G; Charles, Philip; Martinez, Fernando Estrada; Steers, Graham; Fischer, Oliver M; Mueller, Joerg; Hess-Stumpp, Holger; Steinmeyer, Andreas; Manek, Sanjiv; Zondervan, Krina T; Kennedy, Stephen; Becker, Christian M; Shang, Catherine; Zollner, Thomas M; Kessler, Benedikt M; Oppermann, Udo.
Afiliación
  • Thézénas ML; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • De Leo B; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Laux-Biehlmann A; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Bafligil C; Botnar Research Centre, NIHR Biomedical Research Unit Oxford, Nuffield Department of Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
  • Elger B; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Tapmeier T; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Morten K; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Rahmioglu N; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Dakin SG; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Charles P; Botnar Research Centre, NIHR Biomedical Research Unit Oxford, Nuffield Department of Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
  • Martinez FE; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Steers G; Botnar Research Centre, NIHR Biomedical Research Unit Oxford, Nuffield Department of Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
  • Fischer OM; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Mueller J; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Hess-Stumpp H; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Steinmeyer A; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Manek S; Bayer AG, R&D, Gynaecological Therapies, 13342, Berlin, Germany.
  • Zondervan KT; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Kennedy S; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Becker CM; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Shang C; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Zollner TM; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
  • Kessler BM; Botnar Research Centre, NIHR Biomedical Research Unit Oxford, Nuffield Department of Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
  • Oppermann U; Endometriosis CaRe Centre, Nuffield Department of Obstetrics & Gynaecology, Oxford, UK.
Sci Rep ; 10(1): 5665, 2020 Mar 24.
Article en En | MEDLINE | ID: mdl-32205848

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido